Related Experiment Videos

Estimation of the size of myocardial infarct and its clinical application

Acta Medica Polona
|January 1, 1989
PubMed

Insights

This study estimates infarct size using creatine kinase-MB (CK-MB) activity, finding a correlation with ejection fraction. Significant differences arise when myocardial necrosis affects the right ventricle.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Imaging

Background:

  • Myocardial infarction (MI) diagnosis relies on biomarkers and imaging.
  • Creatine Kinase-MB (CK-MB) is an enzyme released during heart muscle damage.
  • Ejection fraction (EF) quantifies heart pump efficiency.

Purpose of the Study:

  • To calculate infarct size using CK-MB activity.
  • To correlate infarct size with ejection fraction.
  • To assess the impact of right ventricular involvement on EF estimation.

Main Methods:

  • CK-MB activity was measured in 16 patients.
  • Infarct size was calculated using a proprietary computer program.
  • Ejection fraction was determined via hemodynamic studies and solely from CK-MB activity changes.

Main Results:

  • A significant correlation was found between infarct size and ejection fraction (p=0.01).
  • Distinct differences in ejection fraction values were observed when right ventricular myocardial necrosis occurred concurrently.
  • CK-MB activity provided a basis for estimating infarct size and, indirectly, ejection fraction.

Conclusions:

  • CK-MB activity estimation is a viable method for calculating infarct size.
  • Right ventricular involvement complicates accurate ejection fraction assessment based on CK-MB alone.
  • This approach offers insights into myocardial necrosis extent and its impact on cardiac function.

Related Concept Videos